What LIFE AI does

LIFE AI (legally LIFE AI Foundation) is a Singapore-incorporated non-profit founded in 2017 by Dr. Tuan Cao, a former Google engineering leader. It operates an AI-native blockchain platform for decentralized science in genomics and precision health, anchored by its Biohub infrastructure layer. The Biohub coordinates real-world health data, AI-driven pattern recognition, and human participation through a modular subnet architecture that includes Genetica (genetic testing), PREVANA (preventive healthcare), Life Cloud (infrastructure), Life Unity (community governance), and InfiniteLife (longevity). Data sovereignty is enforced via blockchain-based Gene NFTs secured by Trusted Execution Environments, and the platform processes 15+ petabytes of health intelligence drawn from 550,000+ human contributors and 110,000+ verified identities across 7 countries (U.S., Korea, Hong Kong, Singapore, Indonesia, Thailand, Vietnam).

The company serves three distinct customer segments. Pharmaceutical and biotech firms such as Kalbe Farma (Southeast Asia's largest pharmaceutical company) use the platform for co-development of precision-health products, with the StrokeGENME partnership delivering a documented 24→6 week development compression. Research institutions and hospitals, including Hue Central Hospital and Stanford, Cornell, and UCSF, leverage the platform's large-scale genetic-study infrastructure. Individual consumers access genetic testing, preventive-health services, and personalized recommendations through the LIFE App super app, supported by 100,000+ paid users.

Revenue is generated through a hybrid model that includes genetic testing service fees, enterprise co-development and licensing agreements with pharmaceutical partners, research infrastructure fees, distribution commissions from partner mini-apps operating on the platform, and an emerging AI-first Model-as-a-Service offering validated through the NVIDIA-backed FastTrack AI Accelerator. Strategic partnerships span NVIDIA, GenAI Fund, SOL Corporation International, and Stanford/Cornell/UCSF research collaborations. Total funding raised is approximately $12M, headcount is 51-100, and the company claims $8.65B in coordinated innovation value across 100+ partners.

Name

LIFE AI

Legal name

LIFE AI Foundation

Website

https://lifenetwork.ai

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

51–100 employees

Short description

LIFE AI Foundation operates the Biohub, an AI-native blockchain infrastructure layer for decentralized genomics and precision health. It coordinates 15+ petabytes of real-world health data from 550,000+ contributors across 7 countries, serving pharmaceutical firms, research institutions, and individual consumers through modular subnets including Genetica, PREVANA, and InfiniteLife.

Ownership category

akta.pro rank

Product category

Healthcare AI Infrastructure

NAICS

Software Publishers (51321), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518210)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Prepackaged Software (7372)

akta.pro primary industry

AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)

akta.pro secondary industries

Bioinformatics & Multi-omics Analysis Software (HLAGAJAD), Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC), End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management) (HDAEANAA)

Keywords

• Precision health platform
• Decentralized genomics infrastructure
• AI health data platform
• Blockchain health data sovereignty
• Real-world health analytics

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Precision Health Subscription Services: The LIFE App serves as a super app platform enabling users to access genetic testing services, personalized health recommendations, and community health features. The platform powers precision health services for 100,000+ paid users across seven countries. VIP membership is earned through activity (purchasing 3 genetic testing packages), entitling members to a 30% discount on subsequent tests. Revenue is derived from genetic testing service fees (new packages for first-time users, unlock packages for existing users expanding analyzed genetic data). All testing is performed by licensed partners such as Genetica.
2. Pharmaceutical & Biotech Partnership Revenue: LIFE AI provides its Biohub infrastructure to pharmaceutical and biotech companies for developing precision health products. Kalbe Farma launched StrokeGENME (personalized stroke prevention) using LIFE AI's platform, demonstrating 10x–30x reduction in development costs. Revenue generated through co-development agreements, platform licensing fees, and outcome-based arrangements with pharma partners.
3. Research Infrastructure & Platform Licensing: Research institutions and pharmaceutical companies access the Biohub infrastructure to compress validation timelines and reduce research costs. Hue Central Hospital conducted Southeast Asia's largest autism genetics study on the platform for $10K vs. an estimated $1M+. Revenue generated through research collaboration agreements and platform access fees.
4. Distribution Revenue (Partner Mini-Apps): The LIFE App integrates multiple independently operated partner mini-applications. Partners reach engaged health-conscious users through the Human Health Network. LIFE AI generates revenue through distribution partnership fees and revenue-sharing arrangements with product and enterprise teams deploying on the platform.
5. AI-First Model-as-a-Service (MaaS): LIFE AI is transitioning from a traditional model to an AI-first 'Model-as-a-Service' strategy, providing AI compute infrastructure, models, and APIs to enterprise partners for launching life-science products. Supported by GPU resources and technical support from NVIDIA through the FastTrack AI Accelerator program.

Pricing tiers

Go-to-market motion5 records

Distribution channels6 records

Marketing channels6 records

Core offering

LIFE AI operates the Biohub, an AI-native infrastructure layer that integrates real-world health dynamics, biotech innovation, and human participation. The platform aggregates 15+ petabytes of health intelligence from 550,000+ humans, enables blockchain-secured data sovereignty via Gene NFTs, and provides pharmaceutical companies, hospitals, and researchers with infrastructure to compress healthcare product development cycles. Consumer-facing access is delivered through the LIFE App super app, which integrates genetic testing services, personalized health insights, and partner mini-applications.

Product overview

LIFE AI operates a foundational AI-native platform built around the Biohub infrastructure layer, which integrates AI capabilities, biotech innovation, and human participation to coordinate real-world health dynamics. The platform is structured as a platform-plus-modules architecture, with the core Biohub coordinating four key subnets: Genetica (genetic testing and personalized health analysis), Prevana (preventive healthcare subnets deployed nationally), Life Cloud (cloud infrastructure), and InfiniteLife (longevity focus). Community engagement is handled through Life Unity with its PoL contribution-recognition mechanism, while Life Points (LP) serve as internal reward tokens. The LIFE App super app sits at the user-facing layer, integrating partner-operated mini applications. The company serves 100,000+ paid users across seven countries and has demonstrated infrastructure-level impact through products like StrokeGENME (co-developed with Kalbe Farma), which compressed a typical 24-month development cycle into 6 weeks.

Differentiator

Problem solved

Functional benefit

Brands

• Biohub: The infrastructure layer for human health that integrates AI capabilities, biotech innovation, and human participation in one infrastructure layer.
• Genetica
• PREVANA
• InfiniteLife
• Life Unity
• Life Cloud
• StrokeGENME

Products and services

• Biohub The foundational AI-native infrastructure layer of LIFE AI, integrating AI capabilities, biotech innovation, and human participation to coordinate real-world health dynamics across 550,000+ humans, 15+ petabytes of health data, and 110,000+ verified identities. Serves as the coordination layer for capital allocators, research institutions, pharmaceutical companies, and product teams building precision health applications.
• LIFE App
• Genetica
• Prevana A preventive healthcare subnet within the Biohub ecosystem, deployed nationally in Thailand as the first large-scale validation environment. Delivers AI-enabled health insights integrated with community health infrastructure to shift healthcare from reactive treatment toward continuous, preventive lifecare.
• Life Cloud
• Life Unity
• InfiniteLife
• StrokeGENME A genetics-powered platform co-developed with Kalbe Farma that translates DNA insights into individualized stroke-prevention plans, delivered through Kalbe's nationwide ecosystem across Indonesia. Achieved a 10x-30x reduction in development costs and compressed development from 24 months to 6 weeks compared to traditional approaches.

Quantifiable outcome

• Healthcare product development compressed from 24 months to 6 weeks (16x faster)
• +7 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature7 records

Partnerships

14 partnerships are on record, tiered major, core, flagship, strategic and minor.

• New Turing InstitutemajorStrategic or Co-development Partner · 29 May 2026New Turing Institute co-organized the GStar Summit 2026 (human-centered AI conference in Ho Chi Minh City, Vietnam) alongside Pacific Gateway Partners. The summit attracted over 1,000 participants from 160+ companies and institutions, with speakers from Google DeepMind, NVIDIA, Meta, and SK Group. The event marked Vietnam's growing strategic role in the Asia-Pacific AI landscape.
• Pacific Gateway PartnersmajorStrategic or Co-development Partner · 29 May 2026Pacific Gateway Partners co-organized the GStar Summit 2026 alongside the New Turing Institute. The summit positioned Vietnam as a growing strategic hub in the Asia-Pacific AI landscape and reinforced LIFE AI's presence in the regional AI ecosystem.
• Volunteer Medical Association (Thailand)coreStrategic or Co-development Partner · 12 January 2026Thailand's largest medical volunteer organization partnered with LIFE AI for the nationwide deployment of the PREVANA subnet. VMA's nationwide network of volunteer healthcare providers enables PREVANA to reach Thai communities across urban centers and remote areas, extending the Biohub's infrastructure reach at unprecedented scale through trusted human presence in the preventative lifecare journey.
• NVIDIA Inception ProgramcoreTechnology or Integration · 27 October 2025LIFE AI participates in the NVIDIA Inception Program as part of the FastTrack AI Accelerator. NVIDIA provides GPU resources, technical support from NVIDIA experts, and cloud provider infrastructure. Life AI's Parkinson's drug discovery platform was accelerated by 40% through AI-driven in-silico design using NVIDIA infrastructure. The partnership validates LIFE AI's technical infrastructure capabilities.
• SOL Corporation InternationalmajorStrategic or Co-development Partner · 29 November 2024LIFE AI signed a strategic partnership agreement with SOL Corporation International, a prominent healthcare company in Asia. SOL Corporation aims to bring protective and healthcare solutions developed with Nano Gold technology to the people of Asia. SOL views LIFE AI as a key enabler for traditional Web2 companies to transition into the Web3 ecosystem, expanding customer reach and delivering tailored services with unprecedented precision.
• Kalbe Farma (PT Kalbe Farma Tbk)flagshipStrategic or Co-development PartnerKalbe Farma, Southeast Asia's largest publicly listed pharmaceutical company, partnered with LIFE AI to launch StrokeGENME — a genetics-powered platform translating DNA insights into individualized stroke-prevention plans delivered through Kalbe's nationwide ecosystem. Development was compressed from 24 months to 6 weeks at 10x–30x lower cost. Kalbe serves millions through its extensive network in medicine, diagnostics, and clinical services across Indonesia. The partnership represents LIFE AI's flagship enterprise commercial reference.
• Hue Central HospitalcoreStrategic or Co-development PartnerHue Central Hospital conducted Southeast Asia's largest autism genetics study (5,000 patients) on LIFE AI infrastructure for $10K instead of an estimated $250K+. The study was published in a top-tier peer-reviewed journal at 25x lower cost than traditional research pathways. This partnership demonstrates the Biohub's ability to enable large-scale clinical research at dramatically reduced cost.
• Stanford University, Cornell University, UCSFcoreStrategic or Co-development PartnerLIFE AI maintains research collaborations with scientists from Stanford, Cornell, and UCSF. The company was founded by engineers and scientists from Cornell University, UC Berkeley, and UCSF. These academic partnerships support research validation, scientific rigor, and peer-reviewed publication of research conducted on the Biohub infrastructure.
• GooglestrategicStrategic or Co-development PartnerGoogle served as a strategic partner for GStar Summit 2026, a human-centered AI conference in Ho Chi Minh City, Vietnam. The summit featured executives from Google DeepMind among 20 world-class speakers discussing agentic AI, education in the AI era, and AI applications across industries.
• FPTstrategicStrategic or Co-development PartnerFPT served as a strategic partner for GStar Summit 2026 alongside Google. FPT is a major Vietnamese technology corporation and one of Vietnam's leading AI players, contributing to discussions on AI applications across industries in the Asia-Pacific region.
• GrabminorOthersGrab was listed as a supporter for GStar Summit 2026 alongside LIFE AI, Vietnam Airlines, Calif, Galaxy Holdings, and VNG. The summit marked Vietnam's growing strategic role in the Asia-Pacific AI landscape.
• VNGminorOthersVNG was listed as a supporter for GStar Summit 2026 alongside LIFE AI, Grab, Vietnam Airlines, Calif, and Galaxy Holdings. VNG is a leading Vietnamese technology company.
• GeneticacoreTechnology or IntegrationGenetica is a licensed partner providing genetic testing services through the LIFE AI platform. LIFE AI facilitates user access to genetic testing and personalized health analysis through Genetica. Genetica created Southeast Asia's largest native genetic dataset with over 99% decoding accuracy and has provided over 2 million personalized health recommendations. Genetica is a subnet within the Biohub ecosystem.
• BlockchangeminorOthersListed as a partner logo alongside Kalbe Farma, ParaFi, and Avalanche on the LIFE AI Biohub homepage under partner/ecosystem section.

Scale indicators13 records

Recent moves7 records

Expansion highlights6 records

Emerging players

• iCarbonX: iCarbonX combines multi-omics, AI, and consumer health data to build digital health profiles and partner with pharma on precision medicine. Comparable to LIFE AI's integration of multi-omics, lifestyle, and outcomes data for AI-driven health insights, though focused on a Chinese consumer ecosystem.
• Medable: Medable provides a decentralized clinical trial platform that connects sponsors, sites, and patients for faster, more representative studies. Comparable to LIFE AI's Biohub in enabling clinical and real-world research at lower cost and faster timelines, though focused specifically on trial execution rather than genomic infrastructure.
• Nebula Genomics: Nebula Genomics offers decentralized, blockchain-based whole-genome sequencing with user data ownership and privacy protections. Directly comparable to LIFE AI's Gene NFT and blockchain data sovereignty model in the Web3/decentralized genomics niche, though Nebula is significantly smaller and less integrated with pharma and research workflows.

Broad incumbents

• 23andMe: 23andMe is a consumer genomics platform with one of the largest direct-to-consumer genetic databases globally, used historically for ancestry, trait, and health risk insights. Comparable to LIFE AI's consumer genomics + research data approach, though 23andMe is a Western incumbent that LIFE AI explicitly positions its decentralized model against.
• Verily (Alphabet): Verily is Alphabet's life sciences and precision health subsidiary building data platforms, devices, and clinical research infrastructure. Comparable to LIFE AI at the layer of integrated health data infrastructure and clinical research enablement, but as a much larger, broader incumbent with deeper capital and Western market focus.

Direct peers

• Tempus AI: Tempus AI builds an AI-powered precision medicine platform that aggregates molecular and clinical data at scale to enable pharma R&D and clinical decision support. Highly comparable to LIFE AI's Biohub model of using integrated real-world biological data plus AI tooling to accelerate pharma and clinical workflows, though Tempus is more oncology-focused and operates in Western markets.
• Owkin: Owkin uses federated AI on real-world patient data to accelerate drug discovery and clinical research for biopharma partners. Comparable to LIFE AI's approach of combining AI with real-world health dynamics and pharma partnerships, though Owkin is Europe-focused and emphasizes federated learning.
• SOPHiA Genetics: SOPHiA Genetics operates an AI-driven genomics and multimodal data platform used by hospitals and research institutions to standardize and interpret complex genomic and phenotypic data. Closely mirrors LIFE AI's positioning as AI-powered infrastructure that compresses research timelines and enables precision health for hospital and research partners globally.
• DNAnexus: DNAnexus provides a cloud-based biomedical data analysis and management platform used by pharma, biotech, and clinical labs to process genomic and multi-omics data. Directly comparable to LIFE AI's Biohub as a shared infrastructure layer for sequencing, bioinformatics, and clinical research workflows, with similar enterprise R&D customer base.

Others

• Avalanche (blockchain infrastructure): Avalanche is a blockchain platform used by LIFE AI's ecosystem partners and referenced in the Biohub partner ecosystem. Listed as a relevant adjacent enabling technology for LIFE AI's Gene NFT and decentralized infrastructure, rather than a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/LifeNetwork_AI

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LIFE AI